Author(s)
Goldfinger, Stephen E.Keywords
Conflict of InterestContinuing Education
Drug Industry
Economics
Education
Ethics
Financial Support
Guidelines
Health
Health Care
Incentives
Industry
Medical Education
Medical Ethics
Physicians
Pharmaceutical Industry
Full record
Show full item recordOnline Access
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=A+Matter+of+Influence&title=New+England+Journal+of+Medicine.++&volume=316&issue=22&pages=1408-1409&date=1987&au=Goldfinger,+Stephen+E.https://dx.doi.org/10.1056/NEJM198705283162211
http://hdl.handle.net/10822/728416
Abstract
A physician warns about the ethical implications of pharmaceutical industry involvement with continuing medical education programs. He cites examples of conferences arranged for physicians influential in their fields where attendees were educated and lavishly entertained at drug company expense. While acknowledging that pharmaceutical company support of physician education is unlikely to stop, Goldfinger suggests that the medical profession should develop guidelines for its members concerning participation in industry-sponsored programs. (KIE abstract)Date
2015-05-05Identifier
oai:repository.library.georgetown.edu:10822/72841610.1056/NEJM198705283162211
New England Journal of Medicine. 1987 May 28; 316(22): 1408-1409.
0028-4793
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=A+Matter+of+Influence&title=New+England+Journal+of+Medicine.++&volume=316&issue=22&pages=1408-1409&date=1987&au=Goldfinger,+Stephen+E.
http://dx.doi.org/10.1056/NEJM198705283162211
http://hdl.handle.net/10822/728416